Journal
MOLECULAR BIOLOGY REPORTS
Volume 40, Issue 7, Pages 4591-4596Publisher
SPRINGER
DOI: 10.1007/s11033-013-2551-1
Keywords
ALL; CXCL12; TP53; Polymorphisms; Genetic susceptibility
Categories
Funding
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
- Fundacao Araucaria, Programa Pesquisa para o SUS: (shared health management) compartilhada em saude (PPSUS)
- Fundacao Araucaria do Parana, Secretaria da Ciencia
- Tecnologia e Ensino Superior (SETI)
- Fundo Estadual para a Infancia e Adolescencia (FIA/PR) e Secretaria da Familia e Desenvolvimento Social (Seds)
- Londrina State University Coordination for Post graduation (PROPPG-UEL)
Ask authors/readers for more resources
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Genetic polymorphisms in the 3'UTR region of the CXCL12 (rs1801157) and TP53 codon 72 (rs1042522) genes may contribute to susceptibility to childhood ALL because they affect some important processes, such as metastasis regulation and tumor suppression. Thus the objective of the present study was to detect the frequency of two genetic polymorphisms in ALL patients and controls and to add information their impact on genetic susceptibility and prognosis. The CXCL12 and TP53 polymorphisms were tested in 54 ALL child patients and in 58 controls by restriction fragment length polymerase chain reaction and allelic specific chain reaction techniques, respectively. The frequencies of both allelic variants were higher in ALL patients than in the controls and indicated a positive association: OR = 2.44; 95 % CI 1.05-5.64 for CXCL12 and OR = 2.20; 95 % CI 1.03-4.70 for TP53. Furthermore, when the two genetic variants were analyzed together, they increased significantly more than fivefold the risk of this neoplasia development (OR = 5.24; 95 % CI 1.39-19.75), indicating their potential as susceptibility markers for ALL disease and the relevance of the allelic variant combination to increased risk of developing malignant tumors. Future studies may indicate a larger panel of genes involved in susceptibility of childhood ALL and other hematological neoplasias.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available